vTv Therapeutics LLC (vTv) is a clinical-stage pharmaceutical company focused on treating metabolic diseases to minimize their long-term complications through end-organ protection. Our mission is to advance clinical drug candidates discovered with our innovative technology into safe and effective medicines.
vTv has an innovative pipeline of first-in-class small molecule clinical and pre-clinical drug candidates for the treatment of a wide range of metabolic diseases and their long term complications such as type 1 diabetes and Alzheimer’s disease. The company has built its product candidate portfolio through internal discovery and is advancing its product candidates through in-house research and development efforts. The quality of vTv’s product candidate pipeline, scientific team, clinical trial execution and strategic collaborations have enabled it to become a leader in its novel therapeutic targets.